Twelve-year analysis of microbial keratitis trends at a UK tertiary hospital

[1]  F. Falcão-Reis,et al.  Clinical and Microbiological Profile of Bacterial Microbial Keratitis in a Portuguese Tertiary Referral Center—Where Are We in 2015? , 2016, Eye & contact lens.

[2]  P. Garg,et al.  Update on fungal keratitis , 2016, Current opinion in ophthalmology.

[3]  D. Stone,et al.  Ocular Pathogens and Antibiotic Sensitivity in Bacterial Keratitis Isolates at King Khaled Eye Specialist Hospital, 2011 to 2014 , 2016, Cornea.

[4]  R. Jayaswal,et al.  Update on Acanthamoeba Keratitis: Diagnosis, Treatment, and Outcomes , 2016, Cornea.

[5]  V. Galvis,et al.  Shifting Trends in Bacterial Keratitis in Taiwan : A 10-Year Review in a Tertiary-Care Hospital , 2016 .

[6]  R. Nejima,et al.  Clinical Characteristics and Bacteriological Profile of Moraxella Keratitis , 2015, Cornea.

[7]  Savitri Sharma,et al.  Re-appraisal of topical 1% voriconazole and 5% natamycin in the treatment of fungal keratitis in a randomised trial , 2015, British Journal of Ophthalmology.

[8]  T. Lietman,et al.  Association between in vitro susceptibility to natamycin and voriconazole and clinical outcomes in fungal keratitis. , 2014, Ophthalmology.

[9]  Savitri Sharma,et al.  Microbial Analyses of Contact Lens–Associated Microbial Keratitis , 2014, Optometry and vision science : official publication of the American Academy of Optometry.

[10]  A. Geerards,et al.  Clinical presentation and morbidity of contact lens–associated microbial keratitis: a retrospective study , 2014, Graefe's Archive for Clinical and Experimental Ophthalmology.

[11]  S. Tuft,et al.  Initial treatment of Pseudomonas aeruginosa contact lens-associated keratitis with topical chloramphenicol, and effect on outcome , 2013, British Journal of Ophthalmology.

[12]  Y. Shimomura,et al.  Assessment of real-time polymerase chain reaction detection of Acanthamoeba and prognosis determinants of Acanthamoeba keratitis. , 2012, Ophthalmology.

[13]  S. Hornby,et al.  In vitro antibiotic susceptibility patterns of bacterial keratitis isolates in Oxford, UK: a 10-year review , 2011, Eye.

[14]  E. Cohen,et al.  Update on Fungal Keratitis From 1999 to 2008 , 2010, Cornea.

[15]  P. McDonnell,et al.  Bacterial susceptibility to topical antimicrobials and clinical outcome in bacterial keratitis. , 2010, Investigative ophthalmology & visual science.

[16]  Savitri Sharma,et al.  Review of epidemiological features, microbiological diagnosis and treatment outcome of microbial keratitis: Experience of over a decade , 2009, Indian journal of ophthalmology.

[17]  I. Behlau,et al.  Fungal Keratitis: Changing Pathogens and Risk Factors , 2009, Cornea.

[18]  S. Kilvington,et al.  Acanthamoeba keratitis: diagnosis and treatment update 2009. , 2009, American journal of ophthalmology.

[19]  Yanchuang Liang,et al.  Distribution of bacterial keratitis and emerging resistance to antibiotics in China from 2001 to 2004 , 2008, Clinical ophthalmology.

[20]  T. Naduvilath,et al.  Clinical outcomes of keratitis , 2007, Clinical & experimental ophthalmology.

[21]  S. Tuli,et al.  Fungal Keratitis: Emerging Trends and Treatment Outcomes , 2006, Eye & contact lens.

[22]  [National Surveillance of Infectious Keratitis in Japan--current status of isolates, patient background, and treatment]. , 2006, Nippon Ganka Gakkai zasshi.

[23]  G. Sutton,et al.  Six‐year review of Acanthamoeba keratitis in New South Wales, Australia: 1997–2002 , 2005, Clinical & experimental ophthalmology.

[24]  M. Chalita,et al.  Shifting trends in in vitro antibiotic susceptibilities for common ocular isolates during a period of 15 years. , 2004, American journal of ophthalmology.

[25]  K. Wilhelmus,et al.  Influence of fluoroquinolone susceptibility on the therapeutic response of fluoroquinolone-treated bacterial keratitis. , 2003, Archives of ophthalmology.

[26]  D. Seal,et al.  Microbial keratitis in Hong Kong: relationship to climate, environment and contact-lens disinfection. , 2001, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[27]  G. Alexandrakis,et al.  Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones. , 2000, Ophthalmology.

[28]  R Folberg,et al.  Confirmation of confocal microscopy diagnosis of Acanthamoeba keratitis using polymerase chain reaction analysis. , 2000, Archives of ophthalmology.

[29]  J. Baum,et al.  Emerging fluoroquinolone resistance in bacterial keratitis: A 5-year review , 1999 .

[30]  M. Srinivasan,et al.  Epidemiology and aetiological diagnosis of corneal ulceration in Madurai, south India , 1997, The British journal of ophthalmology.

[31]  M. Maguire,et al.  Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. Report from the Bacterial Keratitis Study Research Group. , 1995, Archives of ophthalmology.

[32]  E. Cohen,et al.  Moraxella Keratitis , 1991, Cornea.

[33]  D. Heidemann,et al.  Branhamella catarrhalis keratitis. , 1987, American journal of ophthalmology.

[34]  J. Baum,et al.  A survey of Moraxella corneal ulcers in a derelict population. , 1980, American journal of ophthalmology.